Blueprints for ATP machinery will aid tuberculosis drug design

-


Nature, Published online: 03 July 2024; doi:10.1038/d41586-024-02094-1

Structural insights into how anti-tuberculosis drugs interact with the enzyme that makes ATP in bacteria and humans pave the way for improved drug design to treat the disease and combat antimicrobial resistance.



Source link

Latest news

This AI Agent Is Designed to Not Go Rogue

AI agents like OpenClaw have recently exploded in popularity precisely because they can take the reins of your...

How Chinese AI Chatbots Censor Themselves

Hearing someone talk about digital censorship in China is always either extremely boring or extremely interesting. Most of...

Are You ‘Agentic’ Enough for the AI Era?

Silicon Valley built AI coding agents that can handle most of the grunt work. Now, the most valuable...

OpenAI Announces Major Expansion of London Office

OpenAI has announced plans to turn its London office into its largest research hub outside of the United...

Who’s Your Daddy? A Chatbot

The first time Alesandra Madison’s husband incorporated AI into their relationship was in late 2024.She’d forgotten to do...

Must read

You might also likeRELATED
Recommended to you